There’s no universal safe or danger level. Ideal current ratios vary by industry. A current ratio of 1.0 means the company has $1 in current assets for every $1 in current liabilities. A ratio below 1 ...
LIGHTPATH TECHNOLOGIES, INC. Reconciliation of Non-GAAP Financial Measures and Regulation G Disclosure (unaudited) Three Months Ended September 30, ------------------------------ 2025 2024 ----------- ...
-- AMTD Digital Achieved 1085.9% Increase in Revenue compared to prior period in 2024 -- Total Assets Amounted to US$899.1 million (US$7.17/share) -- Net Assets Amounted to US$548.0 million (US$4.34/ ...
Ziff Davis, Inc. (NASDAQ: ZD) reported unaudited financial results for the third quarter ended September 30, 2025, and reaffirmed its 2025 guidance.
Century Casinos, Inc. (the "Company", "we", "us", or "our") (Nasdaq Capital Market®: CNTY) today announced its financial ...
Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Investopedia / Eliana Rodgers ...
A crypto inheritance plan is vital because losing private keys or seed phrases can permanently make assets like Bitcoin, Ether and NFTs unrecoverable. A strong inheritance plan includes asset ...
Adjusted diluted EPS in the third quarter 2025 excludes $0.35 of amortization of acquisition-related intangible assets ... our current expectations and involve numerous assumptions, known and unknown ...
Transformation Gaining Momentum in Q3 2025 with Estimated Net Change in Cash Limited to €-38m FY25 Profitability and Cash Targets Confirmed as the Genesis Plan Progresses Steadily Q3 2025 estimated ...
Hosted on MSN
BAIC Motor Reports Q3 2025 Financial Results
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest announcement is out from BAIC ...
Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...
In November 2025, Iovance reported that clinical results for IOV-4001, a PD-1 inactivated TIL cell therapy, in previously treated advanced melanoma patients are anticipated in the first quarter of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback